Vaccines Are Safe. A Worrisome Portion Of Our Generic Drugs Are Not

The piece argues that the bigger public-health risk is imported generic drugs, not vaccine safety debates.

It says many generics are made overseas, while FDA oversight has downplayed defects and patient harm.

The article calls for stronger testing, public quality ratings, and procurement changes to reward higher-quality suppliers.

It also urges incentives for domestic manufacturing to improve drug safety and supply-chain resilience.